Literature DB >> 21183834

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

Manjari Quintanar-Solares1, Catherine Yen, Vesta Richardson, Marcelino Esparza-Aguilar, Umesh D Parashar, Manish M Patel.   

Abstract

BACKGROUND: Single-strain rotavirus vaccine was added to the national immunization program in Mexico in May 2007. We assessed the impact of vaccination on the number of diarrhea-related hospitalizations in Mexican children in 2008 and 2009.
METHODS: We obtained data on all-cause diarrhea-related hospitalizations from January 2003 to June 2009 in Mexican children <5 years of age. We compared diarrhea-related hospitalizations during the 2008 and 2009 rotavirus seasons with the median number of diarrhea-related hospitalizations at baseline (2003-2006), before rotavirus vaccine introduction, at 306 Ministry of Health hospitals. We estimated vaccine coverage using administrative data.
RESULTS: A median number of 10,993 diarrhea-related hospitalizations (range: 9877-11958) occurred each prevaccine rotavirus season from 2003 to 2006 among children < 5 years of age. Diarrhea-related hospitalizations decreased by 11% (N = 9836) in 2008 and by 40% (N = 6597) in 2009. The greatest declines occurred in infants < 12 months of age during 2008 (25%) and 2009 (52%), with 1-dose rotavirus vaccination coverage of 74% and 89% during these years, respectively. A 43% decline was also noted among children 12 to 23 months of age during the 2009 season. No declines were noted during either 2008 or 2009 among unvaccinated children >24 months of age during the study period.
CONCLUSIONS: Marked declines in diarrhea-related hospitalizations among vaccine-eligible Mexican children < 24 months of age have occurred during the first 2 complete rotavirus seasons following rotavirus vaccination. Rotavirus-specific surveillance and epidemiologic studies are necessary for a better understanding of the changes in disease epidemiology and public health impact from rotavirus vaccination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21183834     DOI: 10.1097/INF.0b013e3181fefb32

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 2.  Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.

Authors:  E Anthony S Nelson; Ciro A de Quadros; Mathuram Santosham; Umesh D Parashar; Duncan Steele
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

3.  Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.

Authors:  Leslie A Enane; Paul A Gastañaduy; David M Goldfarb; Jeffrey M Pernica; Margaret Mokomane; Banno Moorad; Lingani Masole; Jacqueline E Tate; Umesh D Parashar; Andrew P Steenhoff
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

Review 4.  Rotavirus vaccines: current status and future considerations.

Authors:  Catherine Yen; Jacqueline E Tate; Terri B Hyde; Margaret M Cortese; Benjamin A Lopman; Baoming Jiang; Roger I Glass; Umesh D Parashar
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

5.  Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.

Authors:  Gary Dubin; Jean-François Toussaint; Jean-Pol Cassart; Barbara Howe; Donna Boyce; Leonard Friedland; Remon Abu-Elyazeed; Sylviane Poncelet; Htay Htay Han; Serge Debrus
Journal:  Hum Vaccin Immunother       Date:  2013-08-28       Impact factor: 3.452

Review 6.  Rotavirus vaccines: update on global impact and future priorities.

Authors:  Catherine Yen; Jacqueline E Tate; Manish M Patel; Margaret M Cortese; Benjamin Lopman; Jessica Fleming; Kristen Lewis; Baoming Jiang; Jon Gentsch; Duncan Steele; Umesh D Parashar
Journal:  Hum Vaccin       Date:  2011-12-01

7.  Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance.

Authors:  Mohammad Howidi; Ghazala Balhaj; Hakam Yaseen; Kusuma Gopala; Leen Jan Van Doorn; Rodrigo DeAntonio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.

Authors:  V L Rahajamanana; J L Raboba; A Rakotozanany; N J Razafindraibe; E J P R Andriatahirintsoa; A C Razafindrakoto; S A Mioramalala; C Razaiarimanga; G G Weldegebriel; E Burnett; J M Mwenda; M Seheri; M J Mphahlele; A L Robinson
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

9.  Cost effectiveness of infant vaccination for rotavirus in Canada.

Authors:  Doug Coyle; Kathryn Coyle; Julie A Bettinger; Scott A Halperin; Wendy Vaudry; David W Scheifele; Nicole Le Saux
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico.

Authors:  Marcelino Esparza-Aguilar; Paul A Gastañaduy; Edgar Sánchez-Uribe; Rishi Desai; Umesh D Parashar; Vesta Richardson; Manish Patel
Journal:  Bull World Health Organ       Date:  2013-11-20       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.